Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
The chronological and skeletal ages must be taken into consideration, both in determining the initial dose and in adjusting the dose
then a month without to really make sure that the feeling I had was not a placebo of any sort
After that, you reduce the frequency to once a week for a month before eventually settling into the once-a-month routine
BPC 157 is noted for promoting angiogenesis while TB-500 is known for its role in cell migration and reducing inflammation, creating a comprehensive approach to tissue repair research
B) Human skin & translational findings Post-procedure care: In a randomized regimen after CO 2 laser resurfacing, a copper-tripeptide complex arm was assessed for erythema and appearance over 12 weeks (n20s) (PubMed)
%20_%20Co%20logo.jpg)
